Your missing links are here (23 October 2020)

Some of the best stuff we picked up around the internet

By: Karen O'Hanlon Cohrt - Oct. 23, 2020
News

Top Picks

Research

  • Researchers from Germany and the US develop compact Cascade–Cas3 system for targeted genome engineering. The system that can make larger genomic deletions than is possible with CRISPR-Cas9, with applications in research and potential for gene insertion and replacement strategies within agriculture and therapy.
  • US research team use in vivo delivery of an adenine base editor and a single guide RNA targeting a single mutation to restore sight in adult mice with the inherited retinal disease retinitis pigmentosa. Research findings published in Nature Biomedical Engineering.
  • US and Australian researchers use CRISPR to validate genetic targets that may be used in control strategies against Culex moquitoes, a globally widespread vector of human and animal pathogens. Research findings shared on preprint server bioRxiv.
  • Computer scientists at University of Oxford report crisprSQL, a novel database platform for CRISPR/Cas off-target cleavage assays. The free resource, found here, is an interactive and bioinformatically enhanced collection of CRISPR/Cas9 off-target cleavage studies that aims to support the fields of cleavage profiling, gene editing safety analysis and transcriptomics. Read the research article here.

Delivery

Diagnostics

Industry

Vision and Opinion

Review

Clinical Trials

COVID-19

Heh, huh wow

Tags

HashtagArticleHashtagMissing linksHashtagNews

News: Your missing links are here (23 October 2020)
News: Your missing links are here (23 October 2020)
CLINICAL TRIALS
Sickle Cell Disease, SCD, (NCT06287099)
Sponsors:
Bioray Laboratories
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine